Omega Healthcare Investors (NYSE:OHI) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Omega Healthcare Investors (NYSE:OHI) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports.

According to Zacks, “Omega Healthcare Investors, Inc. was incorporated in the State of Maryland. It is a self-administered real estate investment trust (REIT), investing in income producing healthcare facilities, principally long-term care facilities located in the United States (U.S.) and the United Kingdom (U.K.). The Company provide lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs), independent living facilities and rehabilitation and acute care facilities. It has historically financed investments through borrowings under its revolving credit facilities, private placements or public offerings of its debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods. “

Several other analysts have also commented on OHI. Wells Fargo & Co lifted their price target on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the company a market perform rating in a research report on Friday, August 23rd. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Thursday, September 12th. They set a buy rating and a $47.00 price target on the stock. Raymond James lowered shares of Omega Healthcare Investors from a strong-buy rating to a market perform rating in a research report on Monday, October 21st. Finally, Bank of America reaffirmed a buy rating and set a $44.50 price target on shares of Omega Healthcare Investors in a research report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average target price of $41.98.

OHI stock opened at $41.07 on Wednesday. The firm has a market cap of $9.25 billion, a PE ratio of 13.51, a PEG ratio of 5.76 and a beta of 0.33. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. The firm’s 50 day moving average price is $42.82 and its 200-day moving average price is $38.90. Omega Healthcare Investors has a one year low of $33.39 and a one year high of $45.01.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.63 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.10). The firm had revenue of $199.00 million for the quarter, compared to analysts’ expectations of $194.26 million. Omega Healthcare Investors had a net margin of 38.12% and a return on equity of 8.87%. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.77 EPS. Equities research analysts predict that Omega Healthcare Investors will post 2.95 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Thursday, October 31st will be given a $0.67 dividend. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.66. The ex-dividend date is Wednesday, October 30th. This represents a $2.68 dividend on an annualized basis and a yield of 6.53%. Omega Healthcare Investors’s payout ratio is presently 88.16%.

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $39.00, for a total value of $390,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Michael Ritz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of $42.00, for a total value of $105,000.00. Following the completion of the sale, the chief accounting officer now directly owns 5,485 shares in the company, valued at approximately $230,370. The disclosure for this sale can be found here. In the last three months, insiders sold 45,500 shares of company stock worth $1,822,300. 1.16% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Coastal Investment Advisors Inc. increased its position in shares of Omega Healthcare Investors by 148.4% during the second quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock worth $26,000 after acquiring an additional 408 shares during the period. Krane Funds Advisors LLC purchased a new stake in shares of Omega Healthcare Investors during the second quarter worth $25,000. Redhawk Wealth Advisors Inc. purchased a new stake in shares of Omega Healthcare Investors during the second quarter worth $31,000. Phocas Financial Corp. purchased a new stake in shares of Omega Healthcare Investors during the second quarter worth $32,000. Finally, Kavar Capital Partners LLC purchased a new stake in shares of Omega Healthcare Investors during the second quarter worth $33,000. 69.27% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Story: Profit Margin

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.